Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Shares Shorted: Short Interest Down 56.5% in September

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) saw a significant decline in short interest in September. As of September 30th, there was short interest totaling 1,378,001 shares, a decline of 56.5% from the September 15th total of 3,166,158 shares. Based on an average daily volume of 43,882 shares, the days-to-cover ratio is presently 31.4 days.

Analyst Ratings Changes

Separately, Jefferies Financial Group lowered Kyowa Kirin to a “hold” rating in a research note on Tuesday, September 8th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce”.

Kyowa Kirin Price Performance

Shares of KYKOF stock traded up $0.28 during trading hours on Thursday, reaching $14.40. The stock had a trading volume of 240 shares, compared to its average volume of 19,365. The stock’s fifty day simple moving average is $14.71 and its 200 day simple moving average is $14.42. Kyowa Kirin has a 12 month low of $4.20 and a 12 month high of $15.90.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. is a Japan-based specialty pharmaceutical company that researches, develops, manufactures and markets prescription medicines. The company focuses on therapies for areas including oncology, immunology, nephrology, the central nervous system and rare diseases, with an emphasis on biologics and other innovative treatments.

Its products include Poteligeo (mogamulizumab), an antibody used in certain hematologic cancers and cutaneous T-cell lymphomas, and Crysvita (burosumab), a treatment for disorders involving abnormal phosphate regulation.